A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 1,468 shares of MEDP stock, worth $456,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,468
Previous 2,983 50.79%
Holding current value
$456,004
Previous $1.23 Million 60.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$320.58 - $457.29 $485,678 - $692,794
-1,515 Reduced 50.79%
1,468 $489,000
Q2 2024

Jul 19, 2024

BUY
$372.0 - $424.34 $249,984 - $285,156
672 Added 29.08%
2,983 $1.23 Million
Q1 2024

Apr 22, 2024

BUY
$284.87 - $413.31 $358,936 - $520,770
1,260 Added 119.89%
2,311 $933,000
Q4 2023

Jan 16, 2024

BUY
$227.52 - $312.68 $239,123 - $328,626
1,051 New
1,051 $322,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.